Research ArticleArticle
Characterization of Dasatinib and Its Structural Analogs as CYP3A4 Mechanism-Based Inactivators and the Proposed Bioactivation Pathways
Xiaohai Li, Yuanjun He, Claudia H. Ruiz, Marcel Koenig and Michael D. Cameron
Drug Metabolism and Disposition June 2009, 37 (6) 1242-1250; DOI: https://doi.org/10.1124/dmd.108.025932